These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34047397)

  • 1. Local immune microenvironment of skin may play an important role in the development of pretibial myxedema.
    Chen X; Dong J; Zhang L; Zhao X; Shi R; Pan M; Zheng J
    Exp Dermatol; 2021 Dec; 30(12):1820-1824. PubMed ID: 34047397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretibial myxedema: pathophysiology and treatment options.
    Fatourechi V
    Am J Clin Dermatol; 2005; 6(5):295-309. PubMed ID: 16252929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
    Arnold K; Metcalfe R; Weetman AP
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy.
    Daumerie C; Ludgate M; Costagliola S; Many MC
    Eur J Endocrinol; 2002 Jan; 146(1):35-8. PubMed ID: 11751064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor.
    Chang TC; Wu SL; Hsiao YL; Kuo ST; Chien LF; Kuo YF; Change CC; Chang TJ
    Clin Immunol Immunopathol; 1994 Apr; 71(1):113-20. PubMed ID: 8137554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pretibial myxedema (PTM) with topical steroid ointment application with sealing cover (steroid occlusive dressing technique: steroid ODT) in Graves' patients.
    Takasu N; Higa H; Kinjou Y
    Intern Med; 2010; 49(7):665-9. PubMed ID: 20371956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pretibial myxedema: pathogenetic features and clinical aspects].
    Sabanova EA; Fadeyev VV; Potekaev NN; Lvov AN
    Probl Endokrinol (Mosk); 2019 Jun; 65(2):134-138. PubMed ID: 31271716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of pretibial myxedema associated with Graves' disease: an immunohistochemical study of serum-derived hyaluronan-associated protein.
    Shishido M; Kuroda K; Tsukifuji R; Fujita M; Shinkai H
    J Dermatol; 1995 Dec; 22(12):948-52. PubMed ID: 8648004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema.
    Kamath C; Young S; Kabelis K; Sanders J; Adlan MA; Furmaniak J; Rees Smith B; Premawardhana LD
    Clin Endocrinol (Oxf); 2012 Sep; 77(3):465-70. PubMed ID: 22891608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema.
    Stadlmayr W; Spitzweg C; Bichlmair AM; Heufelder AE
    Thyroid; 1997 Feb; 7(1):3-12. PubMed ID: 9086563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Graves' dermopathy a generalized disorder?
    Peacey SR; Flemming L; Messenger A; Weetman AP
    Thyroid; 1996 Feb; 6(1):41-5. PubMed ID: 8777383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretibial Myxedema Masquerading as a Venous Leg Ulcer.
    Herskovitz I; Hughes O; MacQuhae F; Kirsner RS
    Wounds; 2017 Mar; 29(3):77-79. PubMed ID: 28355140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin G of patients with circumscribed pretibial myxedema of Graves' disease stimulates proteoglycan synthesis in human skin fibroblasts in culture.
    Shishiba Y; Imai Y; Odajima R; Ozawa Y; Shimizu T
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):44-51. PubMed ID: 1519422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pretibial myxedema with dexamethazone injected subcutaneously by mesotherapy needles.
    Vannucchi G; Campi I; Covelli D; Forzenigo L; Beck-Peccoz P; Salvi M
    Thyroid; 2013 May; 23(5):626-32. PubMed ID: 23397966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG, IgA and C3 deposits in the extra-thyroidal manifestations of autoimmune Graves' disease: their in vitro solubilization by intravenous immunoglobulin.
    Antonelli A; Palla R; Casarosa L; Fallahi P; Baschieri L
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S31-5. PubMed ID: 8828945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease.
    Salvi M; De Chiara F; Gardini E; Minelli R; Bianconi L; Alinovi A; Ricci R; Neri F; Tosi C; Roti E
    Eur J Endocrinol; 1994 Aug; 131(2):113-9. PubMed ID: 8075779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural and immunological findings in Graves' disease with pretibial myxedema.
    Konrad K; Brenner W; Pehamberger H
    J Cutan Pathol; 1980 Apr; 7(2):99-108. PubMed ID: 6989863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euthyroid pretibial myxedema.
    Chen JJ; Ladenson PW
    Am J Med; 1987 Feb; 82(2):318-20. PubMed ID: 3812528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease.
    Rapoport B; Alsabeh R; Aftergood D; McLachlan SM
    Thyroid; 2000 Aug; 10(8):685-92. PubMed ID: 11014313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of fibroblast biosynthetic activity by serum of patients with pretibial myxedema.
    Cheung HS; Nicoloff JT; Kamiel MB; Spolter L; Nimni ME
    J Invest Dermatol; 1978 Jul; 71(1):12-7. PubMed ID: 355562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.